Soltis Investment Advisors’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.43M Buy
7,921
+1,614
+26% +$490K 0.19% 115
2026
Q1
$1.35M Sell
6,307
-48,077
-88% -$10.7M 0.09% 186
2025
Q4
$9.31M Sell
54,384
-7,060
-11% -$1.1M 0.61% 31
2025
Q3
$8.23M Sell
61,444
-1,090
-2% -$115K 0.57% 39
2025
Q2
$6.09M Sell
62,534
-260
-0.4% -$20.6K 0.48% 55
2025
Q1
$4.57M Buy
62,794
+829
+1% +$65.3K 0.41% 69
2024
Q4
$4.48M Buy
61,965
+265
+0.4% +$20.1K 0.41% 68
2024
Q3
$5.04M Buy
61,700
+90
+0.1% +$7.83K 0.49% 62
2024
Q2
$6.56M Buy
61,610
+150
+0.2% +$14.4K 0.69% 37
2024
Q1
$5.97M Buy
+61,460
New +$5.41M 0.67% 43

Other funds holding LRCX

Soltis Investment Advisors's LRCX Position: Q2 2026 in Review

Soltis Investment Advisors increased its Lam Research (LRCX) stake by 26% in Q2 2026, buying an estimated $490K and bringing the position to 7,921 shares worth $3.43M. The position accounts for 0.19% of the portfolio, ranked #115.

Soltis Investment Advisors first reported a position in LRCX in Q1 2024 and has held it in 10 quarters since. The position peaked at $9.31M in Q4 2025. 3,123 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

  • Soltis Investment Advisors held 7,921 shares of Lam Research worth $3.43M as of Q2 2026.
  • Soltis Investment Advisors bought 1,614 Lam Research shares in Q2 2026, an estimated $490K.
  • Lam Research made up 0.19% of Soltis Investment Advisors's portfolio in Q2 2026, its #115 holding.
  • Soltis Investment Advisors first reported a position in Lam Research in Q1 2024 and has held it in 10 quarters since.
  • Soltis Investment Advisors's Lam Research position peaked at $9.31M in Q4 2025.
  • 3,123 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on Soltis Investment Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.